Development and Validation of a Multi-marker Liquid Bead Array Assay for the simultaneous detection of PIK3CA and ESR1 hotspot mutations in single circulating tumor cells (CTCs)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and Validation of a Multi-marker Liquid Bead Array Assay for the simultaneous detection of PIK3CA and ESR1 hotspot mutations in single circulating tumor cells (CTCs)

Published:2024-09 Issue: Volume: Page:e37873
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Stergiopoulou Dimitra,Georgoulias Vassilis,Markou Athina,Lianidou Evi^ORCID

Publisher

Elsevier BV

Reference52 articles.

1. Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began;Meisel;Am Soc Clin Oncol Educ Book,2018

2. PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer;Fusco;Front Oncol,2021

3. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer;Brett;Breast Cancer Res,2021

4. PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come;De Mattos-Arruda;ESMO Open,2020

5. ESR1 mutations: a new biomarker in breast cancer;Carausu;Expert Rev Mol Diagn,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP